Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients.

Wang S, Wang J, Zhang R, Wang T, Yan D, He Z, Jiang F, Hu C, Jia W.

Cardiovasc Diabetol. 2018 Jan 16;17(1):14. doi: 10.1186/s12933-018-0662-7.

2.

Lipid and Alzheimer's disease genes associated with healthy aging and longevity in healthy oldest-old.

Tindale LC, Leach S, Spinelli JJ, Brooks-Wilson AR.

Oncotarget. 2017 Mar 28;8(13):20612-20621. doi: 10.18632/oncotarget.15296.

3.

The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.

Costacou T, Orchard TJ.

J Diabetes Complications. 2016 Mar;30(2):221-6. doi: 10.1016/j.jdiacomp.2015.11.011. Epub 2015 Nov 14.

4.

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ.

Acta Diabetol. 2016 Apr;53(2):243-50. doi: 10.1007/s00592-015-0770-8. Epub 2015 May 24.

5.

Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.

Veiner HL, Gorbatov R, Vardi M, Doros G, Miller-Lotan R, Zohar Y, Sabo E, Asleh R, Levy NS, Goldfarb LJ, Berk TA, Haas T, Shalom H, Suss-Toby E, Kam A, Kaplan M, Tamir R, Ziskind A, Levy AP.

Atherosclerosis. 2015 Mar;239(1):232-9. doi: 10.1016/j.atherosclerosis.2015.01.008. Epub 2015 Jan 14.

6.

Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.

Hu CS, Wu QH, Hu DY.

J Thorac Dis. 2014 Sep;6(9):1319-28. doi: 10.3978/j.issn.2072-1439.2014.07.15. Review.

7.

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH.

Diabetes Care. 2014 Oct;37(10):2843-63. doi: 10.2337/dc14-1720. Epub 2014 Aug 11. Review. No abstract available.

8.

Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Costacou T, Secrest AM, Ferrell RE, Orchard TJ.

Diab Vasc Dis Res. 2014 Sep;11(5):335-42. doi: 10.1177/1479164114539713. Epub 2014 Jul 3.

9.

Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Orchard TJ, Sun W, Cleary PA, Genuth SM, Lachin JM, McGee P, Paterson AD, Raskin P, Anbinder Y, Levy AP; DCCT/EDIC Research Group.

Diabetes. 2013 Sep;62(9):3218-23. doi: 10.2337/db13-0256. Epub 2013 Jun 12.

10.

A review of haptoglobin typing methods for disease association study and preventing anaphylactic transfusion reaction.

Ko DH, Chang HE, Kim TS, Song EY, Park KU, Song J, Han KS.

Biomed Res Int. 2013;2013:390630. doi: 10.1155/2013/390630. Epub 2013 Feb 28. Review.

11.

Patient selection and vitamin E treatment in diabetes mellitus.

Goldenstein H, Levy NS, Lipener YT, Levy AP.

Expert Rev Cardiovasc Ther. 2013 Mar;11(3):319-26. doi: 10.1586/erc.12.187. Review.

12.

Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.

Adams JN, Cox AJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW.

Cardiovasc Diabetol. 2013 Feb 11;12:31. doi: 10.1186/1475-2840-12-31.

13.

Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.

Goldenstein H, Levy NS, Levy AP.

Pharmacol Res. 2012 Jul;66(1):1-6. doi: 10.1016/j.phrs.2012.02.011. Epub 2012 Mar 23. Review.

14.

Haptoglobin genotype and its role in diabetic cardiovascular disease.

Costacou T, Levy AP.

J Cardiovasc Transl Res. 2012 Aug;5(4):423-35. doi: 10.1007/s12265-012-9361-z. Epub 2012 Mar 24. Review.

Supplemental Content

Support Center